Financhill
Sell
15

GMRE Quote, Financials, Valuation and Earnings

Last price:
$7.39
Seasonality move :
20.46%
Day range:
$7.27 - $7.43
52-week range:
$6.75 - $10.46
Dividend yield:
11.37%
P/E ratio:
739.00x
P/S ratio:
3.52x
P/B ratio:
1.08x
Volume:
427.9K
Avg. volume:
610.4K
1-year change:
-9.66%
Market cap:
$494.2M
Revenue:
$138.4M
EPS (TTM):
$0.01

Earnings Data

Next earnings date for GMRE
May 07
2025
Most recent earnings per share
$0.02
Beat by $0.02
(Feb 28/2025)
Consensus Estimate
--
(Feb 28/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

GMRE Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $36.4M -- -- $0.03 --
05/07/2025 Q1 $35.5M -- -- $0.02 --
02/28/2025 Q4 $34.9M $35M $0.02 -- --
11/06/2024 Q3 $34.6M $34.2M $0.03 -- --
08/06/2024 Q2 $34.3M $34.2M -$0.05 -$0.00 -$0.05
05/07/2024 Q1 $34.7M $35.1M $0.01 $0.01 --
02/27/2024 Q4 $35.8M $32.9M -$0.01 $0.01 -$0.02
11/06/2023 Q3 $36M $35.5M $0.05 -- --
08/02/2023 Q2 $36.5M $36.3M $0.18 $0.02 $0.16
05/03/2023 Q1 $36.6M $36.2M $0.01 $0.02 -$0.01
02/28/2023 Q4 -- $36.3M $0.01 -- --
11/02/2022 Q3 -- $35.3M $0.12 -- --
08/03/2022 Q2 -- $33.7M $0.03 -- --
05/04/2022 Q1 -- $31.9M $0.04 -- --
02/28/2022 Q4 -- $30.3M $0.06 -- --
11/03/2021 Q3 -- $30M $0.06 -- --
08/03/2021 Q2 -- $28.2M $0.04 -- --
05/05/2021 Q1 -- $27.3M $0.03 -- --
03/03/2021 Q4 -- $24.9M $0.02 -- --
11/04/2020 Q3 -- $25.1M -$0.22 -- --
08/05/2020 Q2 -- $22M $0.00 -- --
05/06/2020 Q1 -- $21.5M $0.03 -- --
03/04/2020 Q4 -- $20.4M $0.03 -- --
11/06/2019 Q3 -- $18.1M $0.02 -- --
08/07/2019 Q2 -- $16.8M $0.03 -- --
05/08/2019 Q1 -- $15.1M $0.02 -- --
03/06/2019 Q4 -- $14.3M $0.32 -- --
11/05/2018 Q3 -- $14M $0.01 -- --
08/07/2018 Q2 -- $13.2M -$0.00 -- --
05/09/2018 Q1 -- $11.6M $0.02 -- --
03/07/2018 Q4 -- $9.9M -$0.01 -- --
11/09/2017 Q3 -- $8.4M $0.02 -- --
08/10/2017 Q2 -- $7.4M -$0.04 -- --
05/11/2017 Q1 -- $4.6M -$0.07 -- --
12/31/2016 Q4 -- $3.1M -$0.11 -- --
11/10/2016 Q3 -- $1.9M -$0.11 -- --
06/30/2016 Q2 -- $1.8M -$0.35 -- --
03/31/2016 Q1 -- $1.3M -$3.11 -- --
12/31/2015 Q4 -- $656.3K -$3.16 -- --
09/30/2015 Q3 -- $482.1K -$1.99 -- --
06/30/2015 Q2 -- $455.9K -$0.53 -- --

Global Medical REIT Earnings Questions

  • How Much did Global Medical REIT Generate in Revenue Last Quarter?

    Global Medical REIT reported $35M worth of top line sales in its most recent quarter.

  • Did Global Medical REIT Beat Earnings Last Quarter?

    Global Medical REIT announced earnings per share of $0.02 which represents a beat of analyst forecast a -- per share.

  • Is Global Medical REIT Profitable?

    Global Medical REIT reported $27.8M that represents $0.42 per share over the last quarter.

  • What is the Analyst Consensus for Global Medical REIT EPS Next Year?

    Global Medical REIT's earnings are forecast to grow from $0.01 per share to $0.81 per share next year representing an increase of 5200%.

  • When is Global Medical REIT's Earnings Date?

    Global Medical REIT's next earnings date is May 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will MSTY Go By 2030?
How High Will MSTY Go By 2030?

YieldMax’s MSTR Option Income Strategy ETF (MSTY) is a high-yield…

Will NVIDIA Stock Bounce Back?
Will NVIDIA Stock Bounce Back?

After the wild market moves during February and March, investors…

Is Energy Transfer a Good Dividend Stock to Buy Now?
Is Energy Transfer a Good Dividend Stock to Buy Now?

Energy Transfer (NYSE:ET) offers an impressive yield, to say the…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 38x

Alerts

Sell
45
YPF alert for Apr 16

YPF SA [YPF] is down 3.95% over the past day.

Sell
42
RGC alert for Apr 16

Regencell Bioscience Holdings [RGC] is down 1.04% over the past day.

Sell
45
DSDVY alert for Apr 16

DSV AS [DSDVY] is up 9.6% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock